Zimhi

Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding Zimhi SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) […]